Login to Your Account

U.S. war against opioid abuse rages on at DEA, FDA

By Mari Serebrov
Regulatory Editor

Thursday, October 6, 2016

Fewer prescription opioids will be on the U.S. market next year, thanks to sharp reductions in the annual quotas set this week by the Drug Enforcement Administration (DEA) as part of its war on opioid abuse.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription